product pipeline / R&D affecting expense
“Research and development expense increased primarily due to higher personnel-related and project costs.”
IDXX 10-Q
Confirmed
Healthcare Investment Firms
5 names are moving together; 60% are participating in the current session.
1 observed Confirmed episode
Co-movement
Observed member paths adjusted against SPY. Shading marks the latest observation window.
Members
| TICKER | Company | Sector | Today | Observed activity |
|---|---|---|---|---|
| EW | Edwards Lifesciences Corporatio | Healthcare | -0.4% | Group member |
| ISRG | Intuitive Surgical, Inc. | Healthcare | +0.1% | 2/3 observed active sessions |
| IDXX | IDEXX Laboratories, Inc. | Healthcare | +0.2% | 1/3 observed active sessions |
| DXCM | DexCom, Inc. | Healthcare | +1.8% | 1/3 observed active sessions |
| FIGS | FIGS, Inc. | Consumer Cyclical | -0.4% | Group member |
Why we believe this
Cohort
5 namesParticipation
60% this sessionObserved history
7 daily buildsFiling coverage
5/5 membersdemand / volume affecting revenue
“The increase in CAG Diagnostics recurring revenue was primarily due to higher volumes in IDEXX VetLab consumables and reference laboratory testing partially offset by macroeconomic and sector headwinds, as well as benefits from higher realized prices.”
IDXX 10-Q
credit / rates affecting interest expense
“In addition, these alternatives could result in increased interest expense or other dilution of our earnings.”
IDXX 10-Q
This identity theme becomes less useful if activity narrows to one or two names instead of remaining broad across the cohort.
Connected, outside the group
BDX
EWcustomer · Not moving with the group now
Filing receipt · BDX / EW
“We sold (i) our Critical Care product group (“Critical Care”) to Becton, Dickinson and Company (“BD”) in September 2024 and (ii) a business that was not focused on impla…”
EW · customer
MDT
EWpartner · Not moving with the group now
Filing receipt · MDT / EW
“On April 12, 2023, we entered into an intellectual property agreement with Medtronic pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS")…”
EW · partner
AORT
EWcompetitor · Not moving with the group now
Filing receipt · AORT / EW
“We compete with bioprosthetic or mechanical valves from companies including Medtronic, Edwards Lifesciences, Corcym, and Abbott Laboratories.”
EW · competitor
UFPT
ISRGcustomer · Not moving with the group now
Filing receipt · UFPT / ISRG
“Net sales from our largest two customers, Intuitive Surgical SARL and Stryker Corporation, were 24.3% and 21.5%, respectively, of our total net sales for the year ended…”
ISRG · customer
BBNX
DXCMpartner · Not moving with the group now
Filing receipt · BBNX / DXCM
“We have also partnered with Dexcom and Abbott—global leaders in popular and easy to use iCGM technology—to integrate the iLet with the Dexcom G6 and G7 iCGMs and with Ab…”
DXCM · partner
History
2026-07-07 → 2026-07-093 observed active sessions · 14.3% of active names held across the episode